Health and Seniors Care Minister Heather Stefanson has announced that 89 drugs have been added to the provincial formulary. 81 generic medications are included in this announcement.
Stefanson says this will help Manitobans with a number of conditions and disorders pay for their prescription medications.
“Medications can be costly and by adding these drugs to the formulary, we are providing better access and lessening the financial burden so patients can focus on being well.”
Some of the drugs that have been added include:
- Emerade – for the emergency treatment of anaphylactic reactions;
- Ozempic – for the treatment of Type 2 diabetes mellitus;
- Tegsedi – for the treatment of polyneuropathy in patients with hereditary transthyretin amyloidosis;
- Triamcinolone Hexacetonide – for the treatment of pediatric chronic inflammatory arthropathies;
- Humira – for the treatment of polyarticular juvenile idiopathic arthritis and pediatric Crohn’s disease;
- Inlyta – for the treatment of kidney cancer;
- Lynparza – for the treatment of ovarian cancer;
- Xalkori – for the treatment of ROS-1 rearranged non-small cell lung cancer; and
- Try-Jordyna-21 – a generic form of a name-brand birth control pill.
Patients are required to meet pharmacare criteria to be eligible for coverage. You can search for the drugs covered by the Manitoba Pharmacare Program here.
